P Krack1, P Limousin, A L Benabid, P Pollak. Show Affiliations » 1. Department of Clinical and Biological Neurosciences, University of Grenoble, France.
Abstract
Entities: Chemical Disease
Mesh: See more » Antiparkinson Agents/adverse effectsElectric Stimulation TherapyHumansLevodopa/adverse effectsMiddle AgedMovement Disorders/etiologyMovement Disorders/therapyParkinson Disease/therapyThalamic NucleiThalamus/surgeryTreatment Outcome
Substances: See more » Antiparkinson AgentsLevodopa
Year: 1997 PMID: 9400515 DOI: 10.1016/s0140-6736(05)64273-0
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321